Burnell S - Search Results

1

Investigating STEAP2 as a potential therapeutic target for the treatment of aggressive prostate cancer.

Jones LA, Conway GE, Nguyen-Chi A, Burnell S, Jenkins GJ, Conlan RS, Doak SH. Jones LA, et al. Among authors: burnell s. Cell Mol Biol (Noisy-le-grand). 2023 Apr 30;69(4):179-187. doi: 10.14715/cmb/2023.69.4.28. Cell Mol Biol (Noisy-le-grand). 2023. PMID: 37329528

2

Pouring petrol on the flames: Using oncolytic virotherapies to enhance tumour immunogenicity.

Teijeira Crespo A, Burnell S, Capitani L, Bayliss R, Moses E, Mason GH, Davies JA, Godkin AJ, Gallimore AM, Parker AL. Teijeira Crespo A, et al. Among authors: burnell s. Immunology. 2021 Aug;163(4):389-398. doi: 10.1111/imm.13323. Epub 2021 Mar 28. Immunology. 2021. PMID: 33638871 Free PMC article. Review.

3

STEAP2 Knockdown Reduces the Invasive Potential of Prostate Cancer Cells.

Burnell SEA, Spencer-Harty S, Howarth S, Bodger O, Kynaston H, Morgan C, Doak SH. Burnell SEA, et al. Sci Rep. 2018 Apr 19;8(1):6252. doi: 10.1038/s41598-018-24655-x. Sci Rep. 2018. PMID: 29674723 Free PMC article.

4

Increased expression of ARF GTPases in prostate cancer tissue.

Morgan C, Lewis PD, Hopkins L, Burnell S, Kynaston H, Doak SH. Morgan C, et al. Among authors: burnell s. Springerplus. 2015 Jul 12;4:342. doi: 10.1186/s40064-015-1136-y. eCollection 2015. Springerplus. 2015. PMID: 26185744 Free PMC article.

5

Utilisation of the STEAP protein family in a diagnostic setting may provide a more comprehensive prognosis of prostate cancer.

Burnell SEA, Spencer-Harty S, Howarth S, Bodger O, Kynaston H, Morgan C, Doak SH. Burnell SEA, et al. PLoS One. 2019 Aug 8;14(8):e0220456. doi: 10.1371/journal.pone.0220456. eCollection 2019. PLoS One. 2019. PMID: 31393902 Free PMC article. Clinical Trial.

6

Adipose regeneration and implications for breast reconstruction: update and the future.

Combellack EJ, Jessop ZM, Naderi N, Griffin M, Dobbs T, Ibrahim A, Evans S, Burnell S, Doak SH, Whitaker IS. Combellack EJ, et al. Among authors: burnell s. Gland Surg. 2016 Apr;5(2):227-41. doi: 10.3978/j.issn.2227-684X.2016.01.01. Gland Surg. 2016. PMID: 27047789 Free PMC article. Review.

7

Cancer Antigen Discovery Is Enabled by RNA Sequencing of Highly Purified Malignant and Nonmalignant Cells.

Scurr MJ, Greenshields-Watson A, Campbell E, Somerville MS, Chen Y, Hulin-Curtis SL, Burnell SEA, Davies JA, Davies MM, Hargest R, Phillips S, Christian AD, Ashelford KE, Andrews R, Parker AL, Stanton RJ, Gallimore A, Godkin A. Scurr MJ, et al. Among authors: burnell sea. Clin Cancer Res. 2020 Jul 1;26(13):3360-3370. doi: 10.1158/1078-0432.CCR-19-3087. Epub 2020 Mar 2. Clin Cancer Res. 2020. PMID: 32122920

8

Exploiting ECM remodelling to promote immune-mediated tumour destruction.

Pires A, Burnell S, Gallimore A. Pires A, et al. Among authors: burnell s. Curr Opin Immunol. 2022 Feb;74:32-38. doi: 10.1016/j.coi.2021.09.006. Epub 2021 Oct 7. Curr Opin Immunol. 2022. PMID: 34627015 Review.

9

Isolation and characterisation of nasoseptal cartilage stem/progenitor cells and their role in the chondrogenic niche.

Jessop ZM, Al-Sabah A, Simoes IN, Burnell SEA, Pieper IL, Thornton CA, Whitaker IS. Jessop ZM, et al. Among authors: burnell sea. Stem Cell Res Ther. 2020 May 14;11(1):177. doi: 10.1186/s13287-020-01663-1. Stem Cell Res Ther. 2020. PMID: 32408888 Free PMC article.

10

Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity.

Burnell SEA, Capitani L, MacLachlan BJ, Mason GH, Gallimore AM, Godkin A. Burnell SEA, et al. Immunother Adv. 2021 Dec 20;2(1):ltab025. doi: 10.1093/immadv/ltab025. eCollection 2022. Immunother Adv. 2021. PMID: 35265944 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page